IRAK4 scaffolding inhibitor

N/A

Report date: 2025/03/17 16:35:05
NME

Base Information

Drug NameIRAK4 scaffolding inhibitor
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitors
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsDermatitis, AtopicOsteoarthritisHidradenitis Suppurativa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOdyssey Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOdyssey Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicOsteoarthritisHidradenitis Suppurativa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A